529 related articles for article (PubMed ID: 24116154)
21. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
[TBL] [Abstract][Full Text] [Related]
22. AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells.
Ye L; Lam SZ; Yang L; Suzuki K; Zou Y; Lin Q; Zhang Y; Clark P; Peng L; Chen S
Nat Biomed Eng; 2024 Feb; 8(2):132-148. PubMed ID: 37430157
[TBL] [Abstract][Full Text] [Related]
23. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.
Cooney AL; Singh BK; Sinn PL
Mol Ther; 2015 Apr; 23(4):667-74. PubMed ID: 25557623
[TBL] [Abstract][Full Text] [Related]
24. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
25. Detection of Sleeping Beauty transposition in the genome of host cells by non-radioactive Southern blot analysis.
Aravalli RN; Park CW; Steer CJ
Biochem Biophys Res Commun; 2016 Aug; 477(3):317-21. PubMed ID: 27329815
[TBL] [Abstract][Full Text] [Related]
26. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
Yant SR; Ehrhardt A; Mikkelsen JG; Meuse L; Pham T; Kay MA
Nat Biotechnol; 2002 Oct; 20(10):999-1005. PubMed ID: 12244327
[TBL] [Abstract][Full Text] [Related]
27. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB
Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196
[TBL] [Abstract][Full Text] [Related]
28. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
29.
Kovač A; Miskey C; Ivics Z
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834425
[TBL] [Abstract][Full Text] [Related]
30. High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene.
Zhu J; Park CW; Sjeklocha L; Kren BT; Steer CJ
Biochemistry; 2010 Feb; 49(7):1507-21. PubMed ID: 20041635
[TBL] [Abstract][Full Text] [Related]
31. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
32. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
[TBL] [Abstract][Full Text] [Related]
33. AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.
Wang Z; Lisowski L; Finegold MJ; Nakai H; Kay MA; Grompe M
Mol Ther; 2012 Oct; 20(10):1902-11. PubMed ID: 22990673
[TBL] [Abstract][Full Text] [Related]
34. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
35. Targeted Sleeping Beauty transposition in human cells.
Ivics Z; Katzer A; Stüwe EE; Fiedler D; Knespel S; Izsvák Z
Mol Ther; 2007 Jun; 15(6):1137-44. PubMed ID: 17426709
[TBL] [Abstract][Full Text] [Related]
36. Genomic analysis of Sleeping Beauty transposon integration in human somatic cells.
Turchiano G; Latella MC; Gogol-Döring A; Cattoglio C; Mavilio F; Izsvák Z; Ivics Z; Recchia A
PLoS One; 2014; 9(11):e112712. PubMed ID: 25390293
[TBL] [Abstract][Full Text] [Related]
37. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
38. Excision efficiency is not strongly coupled to transgenic rate: cell type-dependent transposition efficiency of sleeping beauty and piggyBac DNA transposons.
Kolacsek O; Erdei Z; Apáti A; Sándor S; Izsvák Z; Ivics Z; Sarkadi B; Orbán TI
Hum Gene Ther Methods; 2014 Aug; 25(4):241-52. PubMed ID: 25045962
[TBL] [Abstract][Full Text] [Related]
39. Development of hyperactive sleeping beauty transposon vectors by mutational analysis.
Zayed H; Izsvák Z; Walisko O; Ivics Z
Mol Ther; 2004 Feb; 9(2):292-304. PubMed ID: 14759813
[TBL] [Abstract][Full Text] [Related]
40. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
